Insights from SABCS24 by Matteo Lambertini
The San Antonio Breast Cancer Symposium (SABCS) 2024 is taking place from December 10-13 in San Antonio, Texas.
The symposium will feature a comprehensive scientific program, including formal lectures by experts, selected slide and poster presentations, and case discussions focused on experimental biology, prevention, diagnosis, and therapy. With an emphasis on clinical, translational, and basic research, SABCS 2024 aims to foster collaboration and knowledge-sharing among academic and private physicians in oncology, as well as patient advocates and other healthcare professionals. The event will be conducted in English, with no simultaneous translation provided, and offers both in-person and virtual participation opportunities.
Matteo Lambertini, Consultant in medical oncology at the IRCCS Policlinico San Martino Hospital, shared his insights from the conference:
General session 2 of SABCS24 by super Icro Meattini
“Presented in general session 2 of SABCS24 by super Icro Meattini results of the interim analysis of the EUROPA trial simultaneously published in The Lancet Oncology really proud for the chance to contribute with Università di Genova, Ospedale San Martino Genova.”
Updated data from the olympiA trial
“Presented at SABCS24 updated data from the olympiA trial showing major benefit of adjuvant olaparib for BRCA carriers with high-risk early Breast Cancer.”
Promising data from PATINA trial
“Very promising data from PATINA trial presented at SABCS24 by Otto Metzger from Dana-Farber Cancer Centre showing the value of maintenance therapy with Endocrine Therapy and palbociclib and dual anti-HER2 therapy in patients with HER2+ advanced Breast Cancer after induction with CT.”
Patient reported outcomes PRO data from COMET trial
“What an extraordinary presentation by super Ann Partridge from Dana Farber Cancer Center
at SABCS24 general session 2 reporting on patient reported outcomes PRO data from COMET trial simultaneously published in JAMA Oncology.”
HER2+ early and advanced Breast Cancer
“What a great discussion by super Aleix Prat, at SABCS24 addressing HER2+ early and advanced Breast Cancer.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023